Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis.
Muller SA, Peiró-Aventin B, Biagioni G, Tini G, Saturi G, Kronberger C, Achten A, Dobner S, Te Rijdt WP, Gasperetti A, Te Riele ASJM, Varrà GG, Ponziani A, Hirsch A, Porcari A, van der Meer MG, Zampieri M, van der Harst P, Kammerlander A, Biagini E, van Tintelen JP, Barbato E, Asselbergs FW, Menale S, Gräni C, Merlo M, Michels M, Knackstedt C, Nitsche C, Longhi S, Musumeci B, Cappelli F, Garcia-Pavia P, Oerlemans MIFJ. Muller SA, et al. Among authors: cappelli f. Eur J Heart Fail. 2024 Sep;26(9):2025-2034. doi: 10.1002/ejhf.3339. Epub 2024 Jun 17. Eur J Heart Fail. 2024. PMID: 38887861 Free article.
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.
Rapezzi C, Quarta CC, Obici L, Perfetto F, Longhi S, Salvi F, Biagini E, Lorenzini M, Grigioni F, Leone O, Cappelli F, Palladini G, Rimessi P, Ferlini A, Arpesella G, Pinna AD, Merlini G, Perlini S. Rapezzi C, et al. Among authors: cappelli f. Eur Heart J. 2013 Feb;34(7):520-8. doi: 10.1093/eurheartj/ehs123. Epub 2012 Jun 28. Eur Heart J. 2013. PMID: 22745357
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.
Gagliardi C, Perfetto F, Lorenzini M, Ferlini A, Salvi F, Milandri A, Quarta CC, Taborchi G, Bartolini S, Frusconi S, Martone R, Cinelli MM, Foffi S, Reggiani MLB, Fabbri G, Cataldo P, Cappelli F, Rapezzi C. Gagliardi C, et al. Among authors: cappelli f. Eur J Heart Fail. 2018 Oct;20(10):1417-1425. doi: 10.1002/ejhf.1285. Epub 2018 Aug 2. Eur J Heart Fail. 2018. PMID: 30070416 Free article.
Real-world versus trial patients with transthyretin amyloid cardiomyopathy.
Canepa M, Tini G, Musumeci B, Cappelli F, Milandri A, Mussinelli R, Autore C, Perfetto F, Rapezzi C, Perlini S. Canepa M, et al. Among authors: cappelli f. Eur J Heart Fail. 2019 Nov;21(11):1479-1481. doi: 10.1002/ejhf.1563. Epub 2019 Jul 24. Eur J Heart Fail. 2019. PMID: 31339212 Free article. No abstract available.
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Musumeci MB, Cappelli F, Russo D, Tini G, Canepa M, Milandri A, Bonfiglioli R, Di Bella G, My F, Luigetti M, Grandis M, Autore C, Perlini S, Perfetto F, Rapezzi C. Musumeci MB, et al. Among authors: cappelli f. JACC Cardiovasc Imaging. 2020 Jun;13(6):1314-1321. doi: 10.1016/j.jcmg.2019.10.015. Epub 2019 Dec 18. JACC Cardiovasc Imaging. 2020. PMID: 31864976 Free article.
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.
Chacko L, Martone R, Bandera F, Lane T, Martinez-Naharro A, Boldrini M, Rezk T, Whelan C, Quarta C, Rowczenio D, Gilbertson JA, Wongwarawipat T, Lachmann H, Wechalekar A, Sachchithanantham S, Mahmood S, Marcucci R, Knight D, Hutt D, Moon J, Petrie A, Cappelli F, Guazzi M, Hawkins PN, Gillmore JD, Fontana M. Chacko L, et al. Among authors: cappelli f. Eur Heart J. 2020 Apr 7;41(14):1439-1447. doi: 10.1093/eurheartj/ehz905. Eur Heart J. 2020. PMID: 31950987
Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus.
Grandis M, Obici L, Luigetti M, Briani C, Benedicenti F, Bisogni G, Canepa M, Cappelli F, Danesino C, Fabrizi GM, Fenu S, Ferrandes G, Gemelli C, Manganelli F, Mazzeo A, Melchiorri L, Perfetto F, Pradotto LG, Rimessi P, Tini G, Tozza S, Trevisan L, Pareyson D, Mandich P. Grandis M, et al. Among authors: cappelli f. Orphanet J Rare Dis. 2020 Dec 14;15(1):348. doi: 10.1186/s13023-020-01633-z. Orphanet J Rare Dis. 2020. PMID: 33317601 Free PMC article.
Emerging Medical Treatment for Hypertrophic Cardiomyopathy.
Argirò A, Zampieri M, Berteotti M, Marchi A, Tassetti L, Zocchi C, Iannone L, Bacchi B, Cappelli F, Stefàno P, Marchionni N, Olivotto I. Argirò A, et al. Among authors: cappelli f. J Clin Med. 2021 Mar 1;10(5):951. doi: 10.3390/jcm10050951. J Clin Med. 2021. PMID: 33804412 Free PMC article. Review.
245 results